New avenues in the medical treatment of Cushing’s disease: corticotroph tumor targeted therapy Maria FleseriuStephan Petersenn Topic Review Open access 15 May 2013 Pages: 1 - 11
MicroRNA biomarkers in glioblastoma Simon Kjær HermansenBjarne Winther Kristensen Topic Review 23 May 2013 Pages: 13 - 23
Caloric restriction reduces edema and prolongs survival in a mouse glioma model Yong-Sheng JiangFu-Rong Wang Laboratory Investigation 24 May 2013 Pages: 25 - 32
Increased glutamate uptake in astrocytes via propentofylline results in increased tumor cell apoptosis using the CNS-1 glioma model Valerie L. JacobsJoyce A. De Leo Laboratory Investigation 22 May 2013 Pages: 33 - 42
Multi-targeted DATS prevents tumor progression and promotes apoptosis in ectopic glioblastoma xenografts in SCID mice via HDAC inhibition Gerald C. Wallace IVCatherine P. HaarArabinda Das Laboratory Investigation 11 June 2013 Pages: 43 - 50
Identification of new HLA-A*0201-restricted cytotoxic T lymphocyte epitopes from neuritin Zhao YangTianzhi ZhaoQingwu Yang Laboratory Investigation Open access 11 June 2013 Pages: 51 - 58
Glutamine synthetase functions as a negative growth regulator in glioma Ying YinWeifeng SunChunxing Liu Laboratory Investigation 19 June 2013 Pages: 59 - 69
Sluggish cognitive tempo in survivors of pediatric brain tumors Victoria W. WillardKristina K. HardyMelanie J. Bonner Clinical Study 10 May 2013 Pages: 71 - 78
Prediagnostic body weight and survival in high grade glioma Erin M. SiegelL. Burton NaborsKathleen M. Egan Clinical Study 11 May 2013 Pages: 79 - 84
Combining two biomarkers, IDH1/2 mutations and 1p/19q codeletion, to stratify anaplastic oligodendroglioma in three groups: a single-center experience J. S. FrenelC. LeuxM. Campone Clinical Study 17 May 2013 Pages: 85 - 91
Cognitive rehabilitation for early post-surgery inpatients affected by primary brain tumor: a randomized, controlled trial Chiara ZucchellaAnnarita CaponeMichelangelo Bartolo Clinical Study 16 May 2013 Pages: 93 - 100
Early and late postoperative seizure outcome in 97 patients with supratentorial meningioma and preoperative seizures: a retrospective study Zhe ZhengPeng ChenJianmin Zhang Clinical Study 24 May 2013 Pages: 101 - 109
Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomide Krishna ReddyLaurie E. GasparChanghu Chen Clinical Study 02 June 2013 Pages: 111 - 116
Comparative analysis of survival, treatment, cost and resource use among patients newly diagnosed with brain metastasis by initial primary cancer Saurabh RayStacey Dacosta-ByfieldApril Teitelbaum Clinical Study 23 May 2013 Pages: 117 - 125
MR perfusion in and around the contrast-enhancement of primary CNS lymphomas Stella BlaselAlina JurcoaneElke Hattingen Clinical Study 22 May 2013 Pages: 127 - 134
O6-methylguanine-DNA methyltransferase (MGMT) immunohistochemistry as a predictor of resistance to temozolomide in primary CNS lymphoma Xiaoyin JiangDavid A. ReardonHenry S. Friedman Clinical Study 18 May 2013 Pages: 135 - 140
Adult primitive neuroectodermal tumors: the prognostic value of supratentorial location Rikesh GandhiRanjith BabuCory Adamson Clinical Study 30 May 2013 Pages: 141 - 148
The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme R. M. BamburyM. Y. TeoS. O’Reilly Clinical Study 19 June 2013 Pages: 149 - 154